VERA
Vera Therapeutics Inc.
Company Overview
| Mkt Cap | $1.92B | Price | $28.46 |
| Volume | 1.54M | Change | -4.08% |
| P/E Ratio | -12.6 | Open | $29.46 |
| Revenue | $2.0M | Prev Close | $29.67 |
| Net Income | $-152.1M | 52W Range | $18.53 - $51.61 |
| Div Yield | N/A | Target | $62.54 |
| Overall | 62 | Value | 60 |
| Quality | 52 | Technical | 75 |
No chart data available
Stock Overview
Updated DailyVera Therapeutics Inc. (VERA) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $28.46 with a market capitalization of $1.92 billion. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows VERA with a volume of 1.54 million shares. The stock opened down 0.71% from yesterday's close of $29.67. Current analyst estimates project earnings of $-4.47 per share for this year, with next year targeting $-4.86.
VERA demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for VERA include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 119.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:32 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VERA | $28.46 | -4.1% | 1.54M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |